Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$111,591,172
+$18,268,301 QoQ
Shares Held
558,934
+13.2% QoQ
Ownership
2.79%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. LGND ranks #36 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $111,591,172 | 558,934 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $93,322,871 | 493,589 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $83,997,839 | 474,189 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $55,564,282 | 488,778 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $48,832,483 | 464,452 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $46,978,953 | 438,441 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $42,865,544 | 428,270 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $34,190,600 | 405,775 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $27,848,907 | 380,970 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $26,483,607 | 370,815 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,129,050 | 352,621 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,630,297 | 341,613 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $23,303,734 | 316,799 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,084,756 | 300,670 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,584,128 | 290,110 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,181,201 | 290,725 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,094,304 | 300,597 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $27,429,215 | 284,663 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,989,015 | 276,015 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $22,715,593 | 277,560 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $25,000,269 | 262,876 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $14,505,362 | 233,807 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,785,779 | 231,836 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $16,807,707 | 240,883 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $11,786,844 | 259,823 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||